Richard M. Stone, MD

    Richard M. Stone, MD

    Clinical director of the Adult Acute Leukemia Program at the Dana-Farber Cancer Institute in Boston

    Drawing First Blood

    • FLT3 Inhibitors in Older Patients with Acute Myeloid Leukemia: More Questions Than Answers? Friday, July 1st, 2016

      Richard M. Stone, MDClinical director of the Adult Acute Leukemia Program at the Dana-Farber Cancer Institute in BostonSelina M. Luger, MDDirector of the Leukemia Program and professor of medicine at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia Acute myeloid leukemia (AML) affects primarily older adults (with a median age of 67 [...]

    back to top
    SHARE